BARALDI, Pier Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 28.775
EU - Europa 9.039
AS - Asia 6.324
SA - Sud America 42
AF - Africa 38
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 27
Totale 44.275
Nazione #
US - Stati Uniti d'America 28.727
CN - Cina 3.310
DE - Germania 2.686
UA - Ucraina 2.238
TR - Turchia 1.691
GB - Regno Unito 955
SG - Singapore 931
IT - Italia 911
SE - Svezia 801
FI - Finlandia 492
RU - Federazione Russa 438
FR - Francia 163
VN - Vietnam 117
PL - Polonia 114
BE - Belgio 59
NL - Olanda 55
IN - India 51
CZ - Repubblica Ceca 37
HK - Hong Kong 36
KR - Corea 32
JP - Giappone 31
ID - Indonesia 30
CA - Canada 28
EU - Europa 24
AU - Australia 23
IR - Iran 22
MA - Marocco 22
TW - Taiwan 21
MX - Messico 20
CL - Cile 18
IL - Israele 16
PK - Pakistan 12
ZA - Sudafrica 12
BR - Brasile 10
RO - Romania 10
CO - Colombia 9
AT - Austria 8
CH - Svizzera 8
HU - Ungheria 8
GR - Grecia 7
IE - Irlanda 7
MY - Malesia 7
NO - Norvegia 7
NZ - Nuova Zelanda 7
ES - Italia 6
PT - Portogallo 5
BG - Bulgaria 4
IQ - Iraq 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
BD - Bangladesh 3
EG - Egitto 3
HR - Croazia 3
LT - Lituania 3
MD - Moldavia 3
DK - Danimarca 2
LU - Lussemburgo 2
PS - Palestinian Territory 2
SI - Slovenia 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
EC - Ecuador 1
IM - Isola di Man 1
KH - Cambogia 1
LK - Sri Lanka 1
MC - Monaco 1
ME - Montenegro 1
MN - Mongolia 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 44.275
Città #
Woodbridge 3.792
Fairfield 3.594
Jacksonville 2.451
Houston 2.445
Chandler 2.077
Ashburn 2.037
Ann Arbor 1.914
Seattle 1.499
Wilmington 1.382
Cambridge 1.093
Izmir 799
Nanjing 772
Singapore 696
Beijing 543
Princeton 512
Boardman 399
San Diego 322
Shenyang 266
Ferrara 263
Nanchang 213
Milan 202
Shanghai 202
Los Angeles 160
Hebei 158
New York 156
San Mateo 154
Bremen 144
Addison 142
Tianjin 141
Changsha 139
Jiaxing 122
Dearborn 114
Dong Ket 114
Jinan 106
Warsaw 104
Santa Clara 98
Philadelphia 88
Falls Church 86
Norwalk 83
Redwood City 78
Kunming 76
Zhengzhou 70
Mountain View 59
Brussels 58
London 57
Munich 55
Ningbo 50
Guangzhou 49
Auburn Hills 47
Orange 47
Verona 43
Amsterdam 37
Des Moines 37
Indiana 37
Taizhou 35
Helsinki 33
Lanzhou 32
Hong Kong 28
Tappahannock 28
Hangzhou 27
Chicago 26
Paris 26
Jakarta 25
Washington 25
Düsseldorf 22
Mcallen 22
Redmond 22
Taipei 21
Augusta 20
Haikou 20
Montréal 20
Brno 19
Duncan 15
Leawood 15
Hefei 14
Kilburn 14
San Francisco 14
Xian 13
Bari 12
Monmouth Junction 12
Weihai 12
Fuzhou 11
Olomouc 11
Rome 11
Yellow Springs 11
Ardabil 10
Marrakesh 10
Chiswick 9
Corvallis 9
Taiyuan 9
Bologna 8
Padova 8
Palo Alto 8
Changchun 7
Dublin 7
Florence 7
Prescot 7
Tokyo 7
Acton 6
Budapest 6
Totale 31.116
Nome #
[2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding to transcription factor Sp1 356
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 330
1,4-Diketones via Isoxazole Intermediates 308
1,2,3-triazolo[5,4-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: A new class of A(2A) adenosine receptor antagonists 290
null 227
A glance at adenosine receptors: Novel target for antitumor therapy 196
A new, efficient synthesis of muscimol (5-ammoniomethylisoxazol-3-olate). 165
1-methyl-3-nitro-5-methoxycarbonyl pyrazole 164
The A3 adenosine receptor: history and perspectives 164
A facile, efficient synthesis of 2-substituted-4-hydroxy-2-cyclopenten-1-ones 158
A synthetic approach for the preparation of rigid analogs of 1,3-dipropyl-7-methyl-8-aryl/heteroarylstyryl xanthines 156
Azaprostaglandin Analogues. Synthesis and Biological Properties of 11-Azaprostaglandin Derivatives 153
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 153
Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor 152
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 151
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 150
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 148
3,5-Disubstituted isoxazoles as a latent aldol moiety: application to the synthesis of (±)-[6]-gingerol. 146
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 146
Geiparvarin analogs. 2. Synthesis and cytostatic activity of 5-(4-arylbutadienyl)-3(2H)-furanones and of N-substituted 3-(4-oxo-2-furanyl)-2-buten-2-yl carbamates. 145
Methyl 4-oxothiolane-3-carboxylate and methyl 2-methyl-4-oxothiolane-3- carboxylate anions as synthetic equivalents of α-acrylate and α-crotonate anions. Formal synthesis of integerrinecic acid 144
History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents 144
A [3+2] nitrile oxide intermolecular cycloaddition approach to 4,5-dihydro-3(2H)-furanone and 3(2H)-furanone ring systems: application to the formal synthesis of (±)-ascofuranone and geiparvarin. 144
Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylation 144
Active γ-manganese dioxide promoted conversion of 4,5-dihydro-1,2-oxazoles to 1,2-oxazoles. 143
Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents 143
Design, Synthesis, DNA Binding, and Biological Evaluation of Water-Soluble Hybrid Molecules Containing Two Pyrazole Analogues of the Alkylating Cyclopropylpyrroloindole (CPI) Subunit of the Antitumor Agent CC-1065 and Polypyrrole Minor Groove Binders. 142
Design, synthesis, in vitro, and in vivo anticancer and antiangiogenic activity of novel 3-arylaminobenzofuran derivatives targeting the colchicine site on tubulin 142
Ethyl 2,4-dioxoalkanoates as starting materials for a convenient route to 3(2H)-furanones and 3(2H)-furanimines 141
Geiparvarin Analogs. 3. Synthesis and cytostatic activity of 3(2H)-furanone and 4,5-dihydro-3(2H)-furanone congeners of geiparvarin, containing a geraniol-like fragment in the side chain 141
3,5-Disubstituted isoxazoles as synthons for (±)-pyrenophorin and (±)-vermiculine synthesis. 141
Synthesis and biological evaluation of 2-and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization 141
Blockade of A2A receptors plus L-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from L-DOPA alone in the rat globus pallidus and substantia nigra reticulata 141
Adenosine receptors and human melanoma 140
Current status of A1 adenosine receptor allosteric enhancers 140
Design, synthesis and in vitro cytotoxicity of a cis-dichloroplatinum(II) complex linked to the minor groove binder stallimycin 139
Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles 139
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1,4] benzodiazepine and minor-groove-binding oligopyrrole carriers 139
A formal total synthesis (±)-forskolin through [3+2] nitrile oxide cycloaddition chemistry 138
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3’,4’,5’-Trimethoxyphenyl)-2-Aryl-1H-Imidazole 138
Geiparvarin Analogs. 4.1. Synthesis and Cytostatic Activity of Geiparvarin Analogs Bearing a Carbamate Moiety or a Furocoumarin Fragment on the Alkenyl Side Chain 137
DNA minor groove binders as potential antitumor and antimicrobial agents 137
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 137
2-Arylamino-4-Amino-5-Aroylthiazoles. "One-Pot" Synthesis and Biological Evaluation of a New Class of Inhibitors of Tubulin Polymerization. 137
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 136
Design, synthesis and growth inhibition activity of bis-epoxyethyl derivatives of stallimycin modified on the amidino moiety 135
Design, synthesis and antiproliferative activity of novel heterobivalent hybrids based on imidazo[2,1-b][1,3,4]thiadiazole and imidazo[2,1-b][1,3]thiazole scaffolds 135
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 135
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 134
A [3 + 2] nitrile oxide cycloaddition approach to retinoids 133
Synthesis of hybrid distamycin-cysteine labeled with 99mTc: a model for a novel class of cancer imaging agents 133
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH) 133
Hybrid molecules based on distamycin A as potential antitumor agents 133
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 133
A convenient synthesis of unsymmetrically substituted terphenyls of biologically active stilbenes via a double Suzuki cross-coupling protocol 133
2,3a,5,6,7,7a-Hexahydro-3H,4H-benzothiophene-3,4-dione and cyclopenta[b]tetrahydrothiophene-3,4-dione enolate anions as synthetic equivalents to cyclohex-2-enone and cyclopent-2-enone C-2-carbanions. 132
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 132
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines structurally related to zaleplon 132
Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor 132
Discovery and Optimization of a Series of 2-Aryl-4-Amino-5-(3 ',4 ',5 '-trimethoxybenzoyl)Thiazoles as Novel Anticancer Agents 132
Design, synthesis and biological evaluation of 3-substituted-2-oxindole hybrid derivatives as novel anticancer agents 131
Synthesis of 2-(5-substituted isoxazol-3-yl)-4-oxo-3-thiazolidinyl alkanoic acids 130
Allosteric modulators for the A1-adenosine receptor 130
A new nitrile oxide based synthesis of the antitumor agent geiparvarin 129
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 128
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation 128
Novel 8-heterocyclyl xanthine derivatives in drug development - An update 128
Synthesis and biological evaluation of 2-(3 ',4 ',5 '-trimethoxybenzoyl)-3-amino 5-aryl thiophenes as a new class of tubulin inhibitors 127
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 127
A new direct glycosylation of pyrimidine, pyrazole, imidazole and purine heterocycles via their N-tetrahydropyranyl (THP) derivatives 127
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4- arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor 126
Total synthesis of (±)-isoclovene. 125
Pyrazolo [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine template: Organic and medicinal chemistry approach 125
Synthesis of syn- and anti-tricyclo[4.1.0.02,4]heptan-5-ones and related compounds. 124
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 124
Synthesis and antitumor activity of novel distamycin derivatives 124
1H-pyrazolo[2,3-d][1,2,4]triazine-3,7-diones as a new class of human leukocyte elastase inhibitors 124
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 124
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 124
Synthesis of new pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine and 1,2,3-triazolo[4,5-e]1,2,4-triazolo[1,5-c]pyrimidine displaying potent and selective activity as A2a adenosine receptor antagonists 123
Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxyphenylsulfonyl)-5-aryl thiophenes as a new class of antitubulin agents 123
Recent improvements in the development of A2B adenosine receptor agonists. 123
A3 adenosine receptor antagonists: History and future perspectives 123
Synthesis of 6‐substituted‐4,5‐dihydro‐3(2H)‐pyridazinones 122
Synthesis and cytotoxic activity of 6-vinyl- and 6-ethynyluridine and 8-vinyl- and 8-ethynyladenosine 122
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 122
Stereospecific nitromethane conjugate addition to 4-oxygenated 2-substituted cyclopent-2-enones: a simple approach to prostaglandins. 121
null 121
Blockade of globus pallidus adenosine A2A receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D 1 or D2 dopamine receptor agonists 121
null 121
Preparation of 3,4-dihydroxy-1-benzeneethanol: a reinvestigation 120
Pyrazole-Related Nucleosides. Synthesis and Antiviral/Antitumor Activity of Some Substituted Pyrazole and Pyrazolo[4,3-d]-1,2,3-triazin-4-one Nucleosides 120
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 120
A new simple synthesis of a-substituted acrylonitriles 120
Allosteric Modulators of the A1 Adenosine receptor 120
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 120
null 120
N-arylpiperazine modified analogues of the P2X(7) receptor KN-62 antagonist are potent inducers of apoptosis of human primary osteoclasts 119
Transient receptor potential ankyrin receptor 1 is a novel target for pro-tussive agents 118
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 118
Totale 14.305
Categoria #
all - tutte 178.050
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.750
Totale 179.800


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.687 0 0 0 1.280 575 1.001 704 875 643 1.046 409 154
2020/20216.321 641 592 270 697 298 649 146 728 122 786 837 555
2021/20225.107 159 470 374 291 374 252 208 244 198 362 528 1.647
2022/20234.812 509 249 108 647 884 775 145 392 614 31 286 172
2023/20242.417 243 309 129 82 170 287 95 398 28 60 56 560
2024/20251.345 292 299 752 2 0 0 0 0 0 0 0 0
Totale 44.745